Clinical Trials Logo

Vaginal Dryness clinical trials

View clinical trials related to Vaginal Dryness.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03666819 Withdrawn - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Start date: September 10, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well carbon dioxide fractional (CO2RE) laser works in treating participants with stage 0-III hormone receptor-positive breast cancer with vulvovaginal atrophy associated with dryness, inflammation or thinning of the epithelial lining of the vulva and vagina. CO2RE laser is a device that delivers controlled CO2 energy to the vaginal tissue and may help treat vaginal symptoms such as itching, burning, painful sexual intercourse, thickened or thin skin of the vulva, and stinging.

NCT ID: NCT01724242 Withdrawn - Breast Cancer Clinical Trials

Vaginal DHEA for Women After Breast Cancer

Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.